483 Celgene Jul 2012

483 Celgene Jul 2012

Jose Cayuela FDA, Justine Tomasso FDA$119.00 - Available Now

FDA investigators audited the Celgene - Summit, NJ, United States facility and issued inspectional observations (via FDA 483) on 30 Jul 2012.

Product details

  • Category: Human Drugs
  • Inspection end: 30 Jul 2012
  • Location: Summit, United States
  • FEI: 3004991673
Add To Cart